Montana State University;N-Gene Research Laboratories Inc.
发明人:
申请号：
EP16177516.8
公开号：
EP3263105A1
申请日:
2016.07.01
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to the use of O-(3-piperidino-2-hydroxy-1- propyl)-nicotinic amidoxime (BGP15), its tautomers, enantiomers and pharmaceutically acceptable salts thereof for the treatment of Familial Dysautonomia.
